CIDARA THERAPEUTICS, INC. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a52ce6d4-fc37-4c87-9c0e-31ee8a6b677e/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $1.3M | 2024-01-01 – 2024-12-31 | evidence 0001610618-25-000017 |
| FY 2023 | $63.9M | 2023-01-01 – 2023-12-31 | evidence 0001610618-24-000041 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001610618-24-000041 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CIDARA THERAPEUTICS, INC. — all facts · Net Income · Operating Income